This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Frankly Speaking CME 188

Podcast

Hydroxychloroquine for COVID-19: Not Ready for Prime-Time - Frankly Speaking EP 188Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato

A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.

Begin

Already listened on another platform?

Claim Credits

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 9/8/2020

Expiration Date: 9/7/2021

Learning Objectives

  • Identify the limitations of using hydroxychloroquine for COVID-19
  • Discuss with patients why hydroxychloroquine is best used for COVID-19 in the setting of a clinical trial
  • Recognize the possible adverse effects of hydroxychloroquine
     

 

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Alan M. Ehrlich, MD, FAAFP

Associate Professor of Family Medicine and Community Health, University of Massachusetts Medical School
Executive Editor, DynaMed 

Learn More

Supporters and Partners

Commercial Supporter

Not Applicable

Education Partner

Not Applicable

Hydroxychloroquine for COVID-19: Not Ready for Prime-Time - Frankly Speaking EP 188

Begin